Gelpac Inc. and Namakor Holdings

Acted for Namakor Holdings and its portfolio company Gelpac Inc., a Canadian leader of high-performance packaging solutions, in the strategic acquisition of WBC Extrusion Products, Inc., a U.S. specialty manufacturer of single-use blown polymer films.

Cominar REIT

Acted for Cominar REIT, one of Canada's largest diversified real estate investment trusts and the largest commercial property owner in Québec, in its C$5.7-billion sale to Iris Acquisition II LP, which is an entity created by a consortium led by Canderel Real Estate Property Inc., one of Canada's largest privately held real estate companies.

BELLUS Health Inc.

Acted for BELLUS Health Inc. in its US$2-billion sale to GSK plc, a British-based pharmaceutical company.

Rogers Sugar Inc.

Acted for Rogers Sugar Inc. in its C$117.9-million equity offering, comprised of a C$57.5-million public offering and C$60.4-million concurrent non-brokered private placements to Fonds de solidarité des travailleurs du Québec (F.T.Q.) and Belkorp Industries Inc., the net proceeds of which will be used to fund a portion of its C$200-million sugar capacity expansion project. 

Slate Asset Management

Acted for Slate Asset Management, the manager and a unitholder of Slate Office REIT, in connection with G2S2 Capital’s activist campaign for board seats and requisition for a special meeting of unitholders of Slate Office REIT, resolved by settlement.

IOU Financial Inc.

Acted for IOU Financial Inc., a fintech company listed on the TSX-V, in its sale to 9494-3677 Québec Inc., a corporation created by a group composed of funds managed by Neuberger Berman, Palos Capital and Fintech Ventures, for an all-cash consideration.

Caisse de dépôt et placement du Québec

Acted for Caisse de dépôt et placement du Québec (Caisse) and CDP Financial Inc. in CDP Financial's establishment and launch of a US$20-billion senior notes program guaranteed by Caisse, including four subsequent offerings by CDP Financial totalling US$8.5 billion in senior notes under the program.

Searchlight Pharma Inc.

Acting for the shareholders of Searchlight Pharma Inc., a top-growth Canadian specialty and innovative branded pharmaceutical company, in connection with the sale of their 100% interest to Apotex Inc., Canada’s largest pharmaceutical company.

Doing Business in Canada 2023, contributor

Nov. 14, 2023 - Davies’ Doing Business in Canada guide provides executives, in-house counsel and foreign investors with an overview of the legal framework governing Canadian business operations and outlines key considerations for investing and conducting business in Canada…

Business Roundtable Issues Expanded “Corporate Purpose” Statement, with Commitment to All Stakeholder Interests

Aug. 27, 2019 - The Business Roundtable, an association of CEOs of major U.S. corporations, recently issued its “Statement on the Purpose of the Corporation. ” The statement underscores the Business Roundtable’s commitment to all stakeholders of corporations, including their customers, employees, suppliers,...

Sébastien Roy Interviewed by Lexpert about Dealmaking in the Maple Syrup Business

Feb. 13, 2018 - Davies partner Sébastien Roy was recently interviewed for a Lexpert Magazine article about transactions in the maple syrup industry, including Rogers Sugar’s (RSI’s) $160.3-million acquisition of L.B. Maple Treat (LBMT) last August. Sébastien believes it was the right time for RSI and...

Multijurisdictional Disclosure System: Offering Securities and Reporting in the United States Using MJDS

Sept. 21, 2015 - The multijurisdictional disclosure system (MJDS) permits eligible Canadian issuers to publicly offer securities in the United States by using a prospectus that is prepared principally in accordance with Canadian disclosure requirements. The MJDS also enables these issuers to substantially satisfy...

Let’s Meet Halfway: CSA Adopts Amendments to Streamline Venture Issuers’ Disclosure

Apr. 15, 2015 - On April 9, 2015, the Canadian Securities Administrators (CSA) announced the adoption of amendments to continuous disclosure, governance and prospectus disclosure requirements (the Amendments).¹ Most of the Amendments streamline the disclosure requirements for venture issuers and aim to...

Public Offering: Prospectus Regime

Sept. 30, 2012 - JurisClasseur Québec, Corporate Law Collection, 2021 Updated Edition (Montréal: LexisNexis Canada)